As of November 2024, Swedish Orphan Biovitrum AB has a market cap of $10.91B. This makes Swedish Orphan Biovitrum AB the world's 1467th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $8.52B | -4.12% |
2023 | $8.88B | 23.78% |
2022 | $7.18B | 16.53% |
2021 | $6.16B | 11.44% |
2020 | $5.53B | 7.51% |
2019 | $5.14B | -19.95% |
2018 | $6.42B | 71.86% |
2017 | $3.74B | 5.25% |
2016 | $3.55B | -20.73% |
2015 | $4.48B | 69.63% |
2014 | $2.64B | 18.88% |
2013 | $2.22B | 82.38% |
2012 | $1.22B | 148.98% |
2011 | $489.05M | -59.44% |
2010 | $1.21B | 45.68% |
2009 | $827.64M | 27.35% |
2008 | $649.92M | -42.63% |
2007 | $1.13B | -33.33% |
2006 | $1.70B | - |